• Resveratrol’s Hormetic Rescue of Radiation-Induced Endotheli

  2026-07-09

  This study establishes a robust in vitro endothelial model to examine how resveratrol rescues vascular injury caused by ionizing radiation. By integrating multiple quantitative assays, the research delineates resveratrol's dose-dependent, hormetic effect on DNA repair and tube formation, offering a platform for screening radioprotective agents.

• Clarithromycin as a CYP3A Inhibitor: Mechanistic Insights &

  2026-07-09

  Explore Clarithromycin's role as a CYP3A inhibitor in drug-drug interaction research, with a focus on mechanistic depth and practical assay design. This article uniquely connects CYP3A inhibition to evolving pharmacokinetic strategies and clinical decision-making.

• DNase I (RNase-free): Mechanistic Leverage in Tumor Microenv

  2026-07-08

  This thought-leadership article explores how DNase I (RNase-free) enables translational researchers to model chemoresistance in complex 3D tumor-stroma co-cultures, facilitating high-fidelity RNA extraction and chromatin analysis. Drawing on recent advances in patient-derived organoid systems, it bridges mechanistic insight with actionable workflow guidance and strategic perspectives for next-generation cancer modeling.

• Anlotinib Hydrochloride Suppresses Angiogenesis via Multi-Ki

  2026-07-08

  The reference study demonstrates that Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, robustly blocks tumor-driven angiogenesis by suppressing VEGFR2, PDGFRβ, and FGFR1 signaling. These findings advance mechanistic understanding and offer practical protocols for researchers investigating angiogenesis and cancer therapy.

• Monomethyl Auristatin E: Advancing ADC Payloads Against Canc

  2026-07-07

  Explore how Monomethyl auristatin E (MMAE) is redefining the strategy for targeting tumor cell plasticity and resistance in solid cancers. This thought-leadership article integrates mechanistic insights, translational guidance, and the latest evidence—including lessons from nasopharyngeal carcinoma research—to help researchers maximize the clinical impact of MMAE-based antibody-drug conjugates.

• Murine RNase Inhibitor: Advanced RNA Protection in RT-PCR Wo

  2026-07-07

  APExBIO’s Murine RNase Inhibitor offers robust, oxidation-resistant RNA protection, outperforming traditional inhibitors in real-time RT-PCR, cDNA synthesis, and advanced sequencing workflows. Learn how its unique biochemistry translates into superior assay reproducibility and discover practical troubleshooting tips for maximizing RNA integrity.

• Ultrasonically Powered Implantable TTF: Advancing Glioblasto

  2026-07-06

  This study introduces a battery-free, ultrasonically powered implantable Tumor Treating Field (i-TTF) system using shape-engineered BaTiO3 nanoparticle pyramid receivers for localized glioblastoma therapy. Key findings include improved wireless energy transfer and significant anti-proliferative effects in vitro and in vivo, addressing longstanding limitations of external TTF devices.

• Dinaciclib (SCH727965) in Cancer Research: Beyond Cell Cycle

  2026-07-06

  Explore how Dinaciclib (SCH727965) advances cancer research by targeting CDK-mediated cell cycle regulation and apoptosis. This article delivers unique insights into tissue boundary biology and practical assay implications, setting it apart from prior discussions.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Models

  2026-07-05

  This study demonstrates that BMP4-GPX4 signaling alleviates ferroptosis in retinal ganglion cells (RGCs) and improves their differentiation following retinal stem cell (RSC) transplantation in a mouse model of glaucoma induced by high intraocular pressure. These findings suggest a promising therapeutic strategy for neuroprotection and functional restoration in glaucomatous damage.

• WNT5a/GSK3/β-catenin Axis Regulates Muscle FAP Adipogenesis

  2026-07-04

  This study uncovers how the WNT5a/GSK3/β-catenin pathway controls adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs), revealing a mechanism underlying muscle fatty degeneration. These insights highlight the potential of Wnt/β-catenin signaling inhibition for modulating cell fate in muscle disease contexts.

• Doxycycline: Applied Workflows in Cancer and Antimicrobial R

  2026-07-03

  Doxycycline stands out as a tetracycline antibiotic with unique dual-action properties, enabling both robust antimicrobial assays and advanced cancer research applications. This guide delivers actionable protocols, troubleshooting strategies, and translational insights, with a focus on APExBIO's high-quality Doxycycline (SKU BA1003) for reproducible results.

• FLAG tag Peptide (DYKDDDDK): Enhancing Recombinant Protein D

  2026-07-03

  The FLAG tag Peptide (DYKDDDDK) streamlines recombinant protein detection and purification, leveraging high solubility and a unique enterokinase-cleavage site. Discover advanced workflow optimizations, practical troubleshooting tips, and pivotal insights from recent motor protein research that set this tag apart for precision applications.

• Gastrin I (human): Strategic Insights for Translational GI R

  2026-07-02

  Explore how Gastrin I (human) advances the modeling of gastric acid secretion using next-generation organoid systems. This thought-leadership article offers mechanistic clarity, practical protocol guidance, and translational strategy tailored to researchers navigating the complexities of gastrointestinal disease modeling and drug development.

• Epacadostat (INCB024360) in Advanced IDO1 Immune Assays

  2026-07-02

  Epacadostat (INCB024360) empowers immuno-oncology labs to unravel IDO1-driven immune modulation with nanomolar precision. This guide translates cutting-edge metabolic immune stimulation protocols into practical workflows, troubleshooting strategies, and actionable assay enhancements leveraging APExBIO's trusted inhibitor.

• BMS-777607: c-Met Inhibitor for Platelet & Cancer Research

  2026-07-01

  BMS-777607 stands out as a versatile c-Met inhibitor, enabling precise MET signaling pathway inhibition in both cancer metastasis models and advanced hiPSC-derived platelet protocols. This guide distills practical workflows, troubleshooting strategies, and protocol enhancements for translational research, with actionable parameters for bench scientists.

16391 records 1/1093 page Next 12345 下5页 Last page